The IPO allotment process for Anondita Medicare Limited is expected to be finalised today, on August 28, 2025. The company launched its Initial Public Offering (IPO) on August 22, 2025, and the bidding window was open till August 26, 2025, for public subscription.
The shares of Anondita Medicare will be listed on the NSE SME, with a tentative listing date of September 1, 2025.
Here is the process to check the Anondita Medicare IPO Allotment Status on NSE:
The Anondita Medicare IPO was a book-building issue of ₹69.50 crores. The issue is entirely a fresh issue of 0.48 crore shares.
The IPO price band was set between ₹137 and ₹145, and the minimum lot size for an application was 1000. The minimum investment amount for an individual investor (retail) was ₹2,74,000.00 (2,000 shares).
Narnolia Financial Services Ltd. was the book running lead manager, and Maashitla Securities Pvt. Ltd. was the registrar of the issue. The market maker of the company was Mansi Share & Stock Broking Pvt.Ltd.
Check out newly Listed IPOs on BSE and NSE.
(August 26, 2025, end of the day)
On Day 3, the Anondita Medicare IPO saw a subscription rate of 300.89 times the issue size. The public issue was subscribed 286.20 times in the individual investors category, 153.03 times in the QIB category, and 531.82 times in the NII category.
According to Investorgain, the Grey Market Premium (GMP) of Anondita Medicare Limited is ₹84 as of August 28, 2025, 08:30 a.m. This indicates that the estimated listing price can be ₹229 as per the upper price band, which is ₹145. The estimated gain per share is 57.93%.
Source: Investorgain Media Report dated August 28, 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Anondita Medicare Limited is a Noida-based manufacturer specialising in male and female condoms, marketed under its flagship brand “COBRA”. The company operates a modern facility with an annual capacity of 562 million condoms and also has a manufacturing plant spread over 100,000 sq. ft.
The company serves both domestic and international markets, supplying to NGOs, government health programs, and export clients across Southeast Asia, Africa, and the Middle East.
In FY25, Anondita Medicare Limited reported a revenue of ₹77 crore and Profit After Tax (PAT) of ₹16.42 crore
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.